170 related articles for article (PubMed ID: 6267277)
1. Inhibition of the renin-angiotensin system. A new approach to the therapy of hypertension.
Ondetti MA; Cushman DW
J Med Chem; 1981 Apr; 24(4):355-61. PubMed ID: 6267277
[No Abstract] [Full Text] [Related]
2. Effects of continuous angiotensin I-converting enzyme blockade on blood pressure, sympathetic activity and renin-angiotensin system in stroke-prone spontaneously hypertensive rats.
Lai FM; Tanikella T; Herzlinger H; Thibault L; Cervoni P
Life Sci; 1981 Mar; 28(12):1309-16. PubMed ID: 6264242
[No Abstract] [Full Text] [Related]
3. Drugs inhibiting the renin - angiotensin system.
Antonaccio MJ; Cushman DW
Fed Proc; 1981 Jun; 40(8):2275-84. PubMed ID: 6263716
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of the renin-angiotensin system as new antihypertensive agents.
Antonaccio MJ
Clin Exp Hypertens A; 1982; 4(1-2):27-46. PubMed ID: 6176373
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic modulation of ACE2 expression.
Soler MJ; Barrios C; Oliva R; Batlle D
Curr Hypertens Rep; 2008 Oct; 10(5):410-4. PubMed ID: 18775121
[TBL] [Abstract][Full Text] [Related]
6. Zinc, angiotensin I-converting enzyme and hypertension.
Lockett CJ; Reyes AJ; Leary WP; Alcocer L; Olhaberry JV
S Afr Med J; 1983 Dec; 64(26):1022-4. PubMed ID: 6316570
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin system in hypertension.
Swales JD
Pharmacol Ther; 1979; 7(1):173-201. PubMed ID: 230525
[No Abstract] [Full Text] [Related]
8. The influence of ACE-inhibition by captopril on renal formation and metabolism of angiotensins I and II in patients with renovascular hypertension.
Hesse B; Rasmussen S; Giese J; Nielsen MD; Høilund-Carlsen PF
Scand J Urol Nephrol Suppl; 1984; 79():45-8. PubMed ID: 6089318
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis and physio-pharmacological actions of angiotensin peptides: 1. Synthetic enzymes.
Haulică I; Bild W; Rădăşanu O
Rev Med Chir Soc Med Nat Iasi; 2006; 110(1):167-72. PubMed ID: 19292099
[TBL] [Abstract][Full Text] [Related]
10. Effect of converting enzyme inhibition with captopril on in vitro angiotensin production in sheep.
Fei DT; Coghlan JP; Scoggins BA
Clin Exp Pharmacol Physiol; 1981; 8(5):447-50. PubMed ID: 6276058
[TBL] [Abstract][Full Text] [Related]
11. [The renin-angiotensin system and its inhibition (author's transl)].
Corvol P; Elkik F; Thibonnier M; Plouin PF; Menard J
Nouv Presse Med; 1981 Apr; 10(19):1525-30. PubMed ID: 6269554
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system inhibitors in proteinuric chronic kidney disease.
Hirsch S
Compr Ther; 2009; 35(2):91-5. PubMed ID: 19618757
[TBL] [Abstract][Full Text] [Related]
13. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
[TBL] [Abstract][Full Text] [Related]
14. [Renin-angiotensin system inhibitors - biochemical and clinical aspects].
Kuska J; Germakowska-Kowalik T; Pluta S
Postepy Hig Med Dosw; 1982; 35(4):395-411. PubMed ID: 6183653
[No Abstract] [Full Text] [Related]
15. Angiotensin converting enzyme inhibition and renin release from the kidney.
Stella A; Macchi A; Genovesi S; Centonza L; Zanchetti A
J Hypertens Suppl; 1989 Sep; 7(7):S21-5; discussion S25-6. PubMed ID: 2559170
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive peptides and hypertension: role of angiotensin converting enzyme.
Johnston CI; Iansek R; Millar JA; McGrath BP; Matthews PG
Aust N Z J Med; 1981; 11(Suppl 1):59-63. PubMed ID: 6266379
[TBL] [Abstract][Full Text] [Related]
17. Effect of chronic captopril treatment on circulating and tissue renin-angiotensin system in SHR rats.
Hu WY; Chen DG; Chen SC; Jin XQ; Wang HJ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):507-12. PubMed ID: 9863143
[TBL] [Abstract][Full Text] [Related]
18. Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I.
Biollaz J; Burnier M; Turini GA; Brunner DB; Porchet M; Gomez HJ; Jones KH; Ferber F; Abrams WB; Gavras H; Brunner HR
Clin Pharmacol Ther; 1981 May; 29(5):665-70. PubMed ID: 6260419
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of the renin-angiotensin system: a major breakthrough in the treatment of arterial hypertension?].
Menard J; Corvol P
Nouv Presse Med; 1980 Feb; 9(9):579-83. PubMed ID: 6244532
[No Abstract] [Full Text] [Related]
20. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
